These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 29892060)
41. p53 enters the microRNA world. Hermeking H Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645 [TBL] [Abstract][Full Text] [Related]
42. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Chen J; Sadowski I Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4813-8. PubMed ID: 15781865 [TBL] [Abstract][Full Text] [Related]
43. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458 [TBL] [Abstract][Full Text] [Related]
44. Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells. Horikawa I; Park KY; Isogaya K; Hiyoshi Y; Li H; Anami K; Robles AI; Mondal AM; Fujita K; Serrano M; Harris CC Cell Death Differ; 2017 Jun; 24(6):1017-1028. PubMed ID: 28362428 [TBL] [Abstract][Full Text] [Related]
45. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Wang S; Guo M; Ouyang H; Li X; Cordon-Cardo C; Kurimasa A; Chen DJ; Fuks Z; Ling CC; Li GC Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1584-8. PubMed ID: 10677503 [TBL] [Abstract][Full Text] [Related]
46. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695 [TBL] [Abstract][Full Text] [Related]
47. Deconstructing networks of p53-mediated tumor suppression in vivo. Kaiser AM; Attardi LD Cell Death Differ; 2018 Jan; 25(1):93-103. PubMed ID: 29099489 [TBL] [Abstract][Full Text] [Related]
48. Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells. Branch P; Masson M; Aquilina G; Bignami M; Karran P Oncogene; 2000 Jun; 19(28):3138-45. PubMed ID: 10918568 [TBL] [Abstract][Full Text] [Related]
49. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Schavolt KL; Pietenpol JA Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570 [TBL] [Abstract][Full Text] [Related]
50. A role for mismatch repair in control of DNA ploidy following DNA damage. Strathdee G; Sansom OJ; Sim A; Clarke AR; Brown R Oncogene; 2001 Apr; 20(15):1923-7. PubMed ID: 11313940 [TBL] [Abstract][Full Text] [Related]
51. The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death. Bock FJ; Tanzer MC; Haschka MD; Krumschnabel G; Sohm B; Goetsch K; Kofler R; Villunger A Sci Rep; 2015 Jun; 5():11268. PubMed ID: 26062895 [TBL] [Abstract][Full Text] [Related]
52. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53. Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291 [TBL] [Abstract][Full Text] [Related]
53. A molecular mechanism of nickel (II): reduction of nucleotide excision repair activity by structural and functional disruption of p53. Kim YJ; Lee YJ; Kim HJ; Kim HS; Kang MS; Lee SK; Park MK; Murata K; Kim HL; Seo YR Carcinogenesis; 2018 Sep; 39(9):1157-1164. PubMed ID: 29931256 [TBL] [Abstract][Full Text] [Related]
54. Hematopoietic stem cell quiescence: yet another role for p53. van Os R; de Haan G; Dykstra BJ Cell Stem Cell; 2009 Jan; 4(1):7-8. PubMed ID: 19128788 [TBL] [Abstract][Full Text] [Related]
55. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899 [TBL] [Abstract][Full Text] [Related]
56. The ability to engage enterocyte apoptosis does not predict long-term crypt survival in p53 and Msh2 deficient mice. Sansom OJ; Clarke AR Oncogene; 2002 Aug; 21(38):5934-9. PubMed ID: 12185594 [TBL] [Abstract][Full Text] [Related]
57. Ezerskyte M; Paredes JA; Malvezzi S; Burns JA; Margison GP; Olsson M; Scicchitano DA; Dreij K Proc Natl Acad Sci U S A; 2018 May; 115(18):4731-4736. PubMed ID: 29666243 [TBL] [Abstract][Full Text] [Related]
58. Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network. Boutelle AM; Mabene AR; Yao D; Xu H; Wang M; Tang YJ; Lopez SS; Sinha S; Demeter J; Cheng R; Benard BA; Valente LJ; Drainas AP; Fischer M; Majeti R; Petrov DA; Jackson PK; Yang F; Winslow MM; Bassik MC; Attardi LD bioRxiv; 2024 Sep; ():. PubMed ID: 39345444 [No Abstract] [Full Text] [Related]